UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 350

Sortiert nach

Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up

Journal of clinical oncology, 2012-10, Vol.30 (30), p.3752-3763

2012

Volltextzugriff (PDF)

Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition

PloS one, 2012-12, Vol.7 (12), p.e51563

2012

Volltextzugriff (PDF)

Flashback Foreword: Radical Cystectomy in the Treatment of Bladder Cancer

Journal of clinical oncology, 2023-08, Vol.41 (22), p.3769-3770

Bosl, George J

2023

Volltextzugriff (PDF)

TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis

Journal of clinical oncology, 2010-04, Vol.28 (10), p.1706-1713

2010

Volltextzugriff (PDF)

Time to publication of oncology trials and why some trials are never published

PloS one, 2017-09, Vol.12 (9), p.e0184025-e0184025

2017

Volltextzugriff (PDF)

CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity

Radiology, 2011-01, Vol.258 (1), p.41

2011

Volltextzugriff (PDF)

Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Tumors

Journal of clinical oncology, 2005-09, Vol.23 (27), p.6549-6555

2005

Volltextzugriff (PDF)

Phase III Randomized Trial of Conventional-Dose Chemotherapy With or Without High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Rescue As First-Line Treatment for Patients With Poor-Prognosis Metastatic Germ Cell Tumors

Journal of clinical oncology, 2007-01, Vol.25 (3), p.247-256

2007

Volltextzugriff (PDF)

Clinical Outcomes of Local and Metastatic Testicular Sex Cord-Stromal Tumors

The Journal of urology, 2014-08, Vol.192 (2), p.415-419

2014

Volltextzugriff (PDF)

Incidence of Metastatic Nonseminomatous Germ Cell Tumor Outside the Boundaries of a Modified Postchemotherapy Retroperitoneal Lymph Node Dissection

Journal of clinical oncology, 2007-10, Vol.25 (28), p.4365-4369

2007

Volltextzugriff (PDF)

Rates of Teratoma and Viable Cancer at Post-Chemotherapy Retroperitoneal Lymph Node Dissection after Induction Chemotherapy for Good Risk Nonseminomatous Germ Cell Tumors

The Journal of urology, 2015-02, Vol.193 (2), p.513-518

2015

Volltextzugriff (PDF)

Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer: Impact of Patient Selection Factors on Outcome

Journal of clinical oncology, 2005-04, Vol.23 (12), p.2781-2788

2005

Volltextzugriff (PDF)

Development and Validation of a Gene-Based Model for Outcome Prediction in Germ Cell Tumors Using a Combined Genomic and Expression Profiling Approach

PloS one, 2015-12, Vol.10 (12), p.e0142846-e0142846

2015

Volltextzugriff (PDF)

Nonrandomized Comparison of Primary Chemotherapy and Retroperitoneal Lymph Node Dissection for Clinical Stage IIA and IIB Nonseminomatous Germ Cell Testicular Cancer

Journal of clinical oncology, 2007-12, Vol.25 (35), p.5597-5602

2007

Volltextzugriff (PDF)

Clinical Outcome and Predictors of Survival in Late Relapse of Germ Cell Tumor

Journal of clinical oncology, 2008-12, Vol.26 (34), p.5524-5529

2008

Volltextzugriff (PDF)

Clinical features, presentation, and tolerance of platinum‐based chemotherapy in germ cell tumor patients 50 years of age and older

Cancer, 2013-07, Vol.119 (14), p.2574-2581

2013

Volltextzugriff (PDF)

Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide in Previously Treated Germ Cell Tumors

Journal of clinical oncology, 2007-01, Vol.25 (1), p.85-90

2007

Volltextzugriff (PDF)

Long-Term Clinical Outcome After Postchemotherapy Retroperitoneal Lymph Node Dissection in Men With Residual Teratoma

Journal of clinical oncology, 2007-03, Vol.25 (9), p.1033-1037

2007

Volltextzugriff (PDF)

Identification and Validation of a Gene Expression Signature That Predicts Outcome in Adult Men With Germ Cell Tumors

Journal of clinical oncology, 2009-11, Vol.27 (31), p.5240-5247

2009

Volltextzugriff (PDF)

Improved Clinical Outcome in Recent Years for Men With Metastatic Nonseminomatous Germ Cell Tumors

Journal of clinical oncology, 2007-12, Vol.25 (35), p.5603-5608

2007

Volltextzugriff (PDF)

Etoposide and Cisplatin Chemotherapy for Metastatic Good-Risk Germ Cell Tumors

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9290-9294

2005

Volltextzugriff (PDF)

Biology and Genetics of Adult Male Germ Cell Tumors

Journal of clinical oncology, 2006-12, Vol.24 (35), p.5512-5518

2006

Volltextzugriff (PDF)

Chemotherapy for Teratoma With Malignant Transformation

Journal of clinical oncology, 2003-12, Vol.21 (23), p.4285-4291

2003

Volltextzugriff (PDF)

Resection of Primary Mediastinal Non-Seminomatous Germ Cell Tumors: A 28-Year Experience at Memorial Sloan-Kettering Cancer Center

Journal of thoracic oncology, 2011-07, Vol.6 (7), p.1236-1241

2011

Volltextzugriff (PDF)

Medical treatment of advanced testicular cancer

JAMA : the journal of the American Medical Association, 2008-02, Vol.299 (6), p.672

2008

Volltextzugriff (PDF)

1 – 25 von 350

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(330)
Mit Volltextzugriff
(274)

Publikationsform

Sprache

Englisch
(350)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

Humans
(252)
Science & Technology
(242)
Life Sciences & Biomedicine
(238)
Male
(208)
Oncology
(169)
Biological And Medical Sciences
(146)
Medical Sciences
(142)
Adult
(134)
Middle Aged
(98)
Tumors
(84)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(79)
Testicular Neoplasms - Pathology
(75)
Testicular Neoplasms - Drug Therapy
(67)
Adolescent
(62)
Neoplasms, Germ Cell And Embryonal - Drug Therapy
(61)
Chemotherapy
(60)
Female
(56)
Pharmacology. Drug Treatments
(55)
Antineoplastic Agents
(51)
Neoplasms, Germ Cell And Embryonal - Pathology
(50)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up

Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition

Flashback Foreword: Radical Cystectomy in the Treatment of Bladder Cancer

TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis

Time to publication of oncology trials and why some trials are never published

CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity

Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Tumors

Phase III Randomized Trial of Conventional-Dose Chemotherapy With or Without High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Rescue As First-Line Treatment for Patients With Poor-Prognosis Metastatic Germ Cell Tumors

Clinical Outcomes of Local and Metastatic Testicular Sex Cord-Stromal Tumors

Incidence of Metastatic Nonseminomatous Germ Cell Tumor Outside the Boundaries of a Modified Postchemotherapy Retroperitoneal Lymph Node Dissection

Rates of Teratoma and Viable Cancer at Post-Chemotherapy Retroperitoneal Lymph Node Dissection after Induction Chemotherapy for Good Risk Nonseminomatous Germ Cell Tumors

Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer: Impact of Patient Selection Factors on Outcome

Development and Validation of a Gene-Based Model for Outcome Prediction in Germ Cell Tumors Using a Combined Genomic and Expression Profiling Approach

Nonrandomized Comparison of Primary Chemotherapy and Retroperitoneal Lymph Node Dissection for Clinical Stage IIA and IIB Nonseminomatous Germ Cell Testicular Cancer

Clinical Outcome and Predictors of Survival in Late Relapse of Germ Cell Tumor

Clinical features, presentation, and tolerance of platinum‐based chemotherapy in germ cell tumor patients 50 years of age and older

Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide in Previously Treated Germ Cell Tumors

Long-Term Clinical Outcome After Postchemotherapy Retroperitoneal Lymph Node Dissection in Men With Residual Teratoma

Identification and Validation of a Gene Expression Signature That Predicts Outcome in Adult Men With Germ Cell Tumors

Improved Clinical Outcome in Recent Years for Men With Metastatic Nonseminomatous Germ Cell Tumors

Etoposide and Cisplatin Chemotherapy for Metastatic Good-Risk Germ Cell Tumors

Biology and Genetics of Adult Male Germ Cell Tumors

Chemotherapy for Teratoma With Malignant Transformation

Resection of Primary Mediastinal Non-Seminomatous Germ Cell Tumors: A 28-Year Experience at Memorial Sloan-Kettering Cancer Center

Medical treatment of advanced testicular cancer

Suchergebnisse filtern